{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T04:05:50Z","timestamp":1746677150553,"version":"3.40.5"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,6]]},"DOI":"10.7759\/cureus.83619","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:27:51Z","timestamp":1746599271000},"source":"Crossref","is-referenced-by-count":0,"title":["Differentiating Systemic Lupus Erythematosus Flare From Preeclampsia in Pregnancy Using the Soluble Fms-Like Tyrosine Kinase-1\/Placental Growth Factor Ratio"],"prefix":"10.7759","author":[{"given":"Akane","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Ogoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihide","family":"Ohkuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-011-8269-8","article-title":"Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital","volume":"44","author":"Ideguchi H","year":"2013","unstructured":"Ideguchi H, Ohno S, Uehara T, Ishigatsubo Y. Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital. Clin Rev Allergy Immunol. 2013, 44:57-64. 10.1007\/s12016-011-8269-8","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203308097575","article-title":"Maternal and foetal outcomes in pregnant patients with active lupus nephritis","volume":"18","author":"Wagner SJ","year":"2009","unstructured":"Wagner SJ, Craici I, Reed D, et al.. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009, 18:342-7. 10.1177\/0961203308097575","journal-title":"Lupus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100997","article-title":"Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis","volume":"38","author":"Bramham K","year":"2011","unstructured":"Bramham K, Hunt BJ, Bewley S, Germain S, Calatayud I, Khamashta MA, Nelson-Piercy C. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011, 38:1906-13. 10.3899\/jrheum.100997","journal-title":"J Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/943490","article-title":"Understanding and managing pregnancy in patients with lupus","volume":"2015","author":"de Jesus GR","year":"2015","unstructured":"de Jesus GR, Mendoza-Pinto C, de Jesus NR, dos Santos FC, Klumb EM, Carrasco MG, Levy RA. Understanding and managing pregnancy in patients with lupus. Autoimmune Dis. 2015, 2015:943490. 10.1155\/2015\/943490","journal-title":"Autoimmune Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001239","article-title":"Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis","volume":"11","author":"Zhu Q","year":"2024","unstructured":"Zhu Q, Wang J, Sun Q, et al.. Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis. Lupus Sci Med. 2024, 11:e001239. 10.1136\/lupus-2024-001239","journal-title":"Lupus Sci Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123454","article-title":"Modern management of pregnancy in systemic lupus erythematosus: from prenatal counseling to postpartum support","volume":"13","author":"Gamba A","year":"2024","unstructured":"Gamba A, Zen M, Depascale R, Calligaro A, Gatto M, Iaccarino L, Doria A. Modern management of pregnancy in systemic lupus erythematosus: from prenatal counseling to postpartum support. J Clin Med. 2024, 13:3454. 10.3390\/jcm13123454","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14445","article-title":"Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with belimumab","volume":"26","author":"Wei SR","year":"2023","unstructured":"Wei SR, Zhu ZZ, Xu J, Mo HY. Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with belimumab. Int J Rheum Dis. 2023, 26:154-6. 10.1111\/1756-185X.14445","journal-title":"Int J Rheum Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxac069","article-title":"A case report of two systemic lupus erythematosus pregnancies with early placental exposure to belimumab: Case report with review","volume":"7","author":"Nakai T","year":"2023","unstructured":"Nakai T, Ikeda Y, Yamaguchi K, et al.. A case report of two systemic lupus erythematosus pregnancies with early placental exposure to belimumab: Case report with review. Mod Rheumatol Case Rep. 2023, 7:82-6. 10.1093\/mrcr\/rxac069","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2023.2205513","article-title":"Maternal and fetal outcomes of SLE in pregnancy: a literature review","volume":"43","author":"Sangah AB","year":"2023","unstructured":"Sangah AB, Jabeen S, Hunde MZ, Devi S, Mumtaz H, Shaikh SS. Maternal and fetal outcomes of SLE in pregnancy: a literature review. J Obstet Gynaecol. 2023, 43:2205513. 10.1080\/01443615.2023.2205513","journal-title":"J Obstet Gynaecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler H","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, et al.. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016, 374:13-22. 10.1056\/NEJMoa1414838","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-021-00629-x","article-title":"Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study","volume":"44","author":"Ohkuchi A","year":"2021","unstructured":"Ohkuchi A, Saito S, Yamamoto T, et al.. Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study. Hypertens Res. 2021, 44:813-21. 10.1038\/s41440-021-00629-x","journal-title":"Hypertens Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge LA","year":"2021","unstructured":"Dr\u00f6ge LA, Perschel FH, St\u00fctz N, et al.. Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study. Hypertension. 2021, 77:461-71. 10.1161\/HYPERTENSIONAHA.120.15146","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren S","year":"2014","unstructured":"Verlohren S, Herraiz I, Lapaire O, et al.. New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014, 63:346-52. 10.1161\/HYPERTENSIONAHA.113.01787","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2018.04.002","article-title":"Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus","volume":"127","author":"Mayer-Pickel K","year":"2018","unstructured":"Mayer-Pickel K, Stern C, Eberhard K, Lang U, Obermayer-Pietsch B, Cervar-Zivkovic M. Angiogenic factors in pregnancies of women with antiphospholipid syndrome and systemic lupus erythematosus. J Reprod Immunol. 2018, 127:19-23. 10.1016\/j.jri.2018.04.002","journal-title":"J Reprod Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.141571","article-title":"Circulating angiogenic factors and the risk of preeclampsia in systemic lupus erythematosus pregnancies","volume":"42","author":"Lea\u00f1os-Miranda A","year":"2015","unstructured":"Lea\u00f1os-Miranda A, Campos-Galicia I, Berumen-Lechuga MG, Molina-P\u00e9rez CJ, Garc\u00eda-Paleta Y, Isordia-Salas I, Ram\u00edrez-Valenzuela KL. Circulating angiogenic factors and the risk of preeclampsia in systemic lupus erythematosus pregnancies. J Rheumatol. 2015, 42:1141-9. 10.3899\/jrheum.141571","journal-title":"J Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24360","article-title":"Soluble Flt-1, placental growth factor, and vascular endothelial growth factor serum levels to differentiate between active lupus nephritis during pregnancy and preeclampsia","volume":"73","author":"de Jes\u00fas GR","year":"2021","unstructured":"de Jes\u00fas GR, Lacerda MI, Rodrigues BC, et al.. Soluble Flt-1, placental growth factor, and vascular endothelial growth factor serum levels to differentiate between active lupus nephritis during pregnancy and preeclampsia. Arthritis Care Res (Hoboken). 2021, 73:717-21. 10.1002\/acr.24360","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-018-0373-7","article-title":"Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy","volume":"8","author":"Hirashima C","year":"2019","unstructured":"Hirashima C, Ogoyama M, Abe M, et al.. Clinical usefulness of serum levels of soluble fms-like tyrosine kinase 1\/placental growth factor ratio to rule out preeclampsia in women with new-onset lupus nephritis during pregnancy. CEN Case Rep. 2019, 8:95-100. 10.1007\/s13730-018-0373-7","journal-title":"CEN Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-013-0092-z","article-title":"Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?","volume":"3","author":"Ohmaru T","year":"2014","unstructured":"Ohmaru T, Ohkuchi A, Muto S, Hirashima C, Matsubara S, Suzuki M. Increased antiangiogenetic factors in severe proteinuria without hypertension in pregnancy: is kidney biopsy necessary?. CEN Case Rep. 2014, 3:86-9. 10.1007\/s13730-013-0092-z","journal-title":"CEN Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367559-differentiating-systemic-lupus-erythematosus-flare-from-preeclampsia-in-pregnancy-using-the-soluble-fms-like-tyrosine-kinase-1placental-growth-factor-ratio","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T06:27:52Z","timestamp":1746599272000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367559-differentiating-systemic-lupus-erythematosus-flare-from-preeclampsia-in-pregnancy-using-the-soluble-fms-like-tyrosine-kinase-1placental-growth-factor-ratio"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.83619","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,6]]}}}